World’s first RSV vaccine approved by FDA  breakthrough 60 years in the making – New York Post

World’s first RSV vaccine approved by FDA breakthrough 60 years in the making – New York Post

Mpox vaccine campaigns in New York aim to prevent another outbreak – Newsday
The FDA has approved the first-ever vaccine for RSV – Science News Magazine
First RSV vaccine approved in U.S. after decades of attempts – CBC.ca
US becomes first country to approve RSV vaccine – Punch Newspapers
Symptom and Viral Rebound in Untreated COVID-19 Patients – Contagionlive.com
COVID-19 Mortality by Race and Ethnicity in the US: Have … – Contagionlive.com
COVID-19 Related Circulars or Guidance (Non-Exhaustive … – Mayer Brown
Bivalent Boosters against Severe Omicron Infection | NEJM – nejm.org
COVID-19 Weekly Update 5-2-2023 – West Virginia Department of Health and Human Resources
Arcturus: New COVID-19 variant spreading in the U.S with new symptom

Arcturus: New COVID-19 variant spreading in the U.S with new symptom

May 4, 2023

Theres a new COVID-19 variant spreading across the globe bringing with it a new symptom.

The World Health Organization identified the new variant as XBB.1.16 or Arcturus.

Here are 9 thing to know about the variant, according to AdventHealth:

1. According to health officials, COVID-19 is still a leading cause of death around the world, including in the United States where its tied to about 250 deaths daily.

2. The World Health Organization is currently classifying XBB.1.16 or Arcturus as a variant under monitoring, which is less serious than variant of interest or variant of concern. However, the classifications are fluid and can change at any time.

Read: CDC survey: One-third of households used federal COVID test kit program

3. AdventHealth said the Arcturus variant has a higher transmissibility rate than previous strains.

4. The new variant brings with it an all-new COVID-19 symptom: conjunctivitis, also known as pink eye, which is often combined with itchiness.

Read: Free COVID testing will fade with US health emergency in May

5. Arcturus is responsible for a surge in COVID case counts in some parts of the world, including India, where itchy or sticky eyes have been most frequently reported in children, along with typical flu-like symptoms of a cough, cold and fever.

6. XBB.1.16 has been detected in 22 countries, including the United States.

7. Out of the 10 health care regions defined by the CDC, Arcturus appears to be the most prevalent in Region 6, which includes Arkansas, Louisiana, New Mexico, Oklahoma and Texas. In that region, it made up 21% of all COVID cases during the week of April 9.

Read: COVID-19 era extra SNAP benefits to end

8. While higher levels of infection are being seen with newer variants, generally, they tend to be causing less severe illness.

9. The less severe illness is likely the result of higher vaccination rates, higher rates of immunity from previous infection and a weakening in the potential to produce disease in recent variants.

Click here to download the free WFTV news and weather apps, click here to download the WFTV Now app for your smart TV and click here to stream Channel 9 Eyewitness News live.


See the original post: Arcturus: New COVID-19 variant spreading in the U.S with new symptom